POSASR: Post-effective Amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR

Exhibit 5.14

March 28, 2017

Omega Healthcare Investors, Inc.

200 International Circle

Suite 3500

Hunt Valley, Maryland 21030

Re:         Post-Effective Amendment No. 2 to Registration Statement on Form S-3 (Registration No. 333-208710)

Ladies and Gentlemen:

We have acted as counsel to Omega Healthcare Investors, Inc., a Maryland corporation (the “Company”) in connection with a Registration Statement on Form S-3 (the “Initial Registration Statement”) filed with the with the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Act”) on December 22, 2015, as amended by Post-Effective Amendment No. 1 dated as of June 30, 2016 (“Amendment No. 1”) and Post-Effective Amendment No. 2 dated as of the date hereof (“Amendment No. 2” and together with the Initial Registration Statement and Amendment No. 1, the “Registration Statement”), being filed by the Company with the Commission under the Act. The Registration Statement relates to (i) debt securities of the Company (the “Debt Securities”), which may be issued under one or more series under one or more indentures or supplemental indentures (the “Indentures”) proposed to be entered into with one or more indenture trustees (each, an “Indenture Trustee”) and (ii) guarantees by one or more of the Company or the Registrant Guarantors (as such term is defined below) of the Debt Securities, including guarantees by one or more of the New Registrant Guarantors (as such term is defined below) (the “New Guarantees,” along with all such guarantees described in this subsection (ii) and together with the Debt Securities are collectively referred to herein as the “Securities”). An indeterminate amount of the Securities may be offered at indeterminate prices from time to time by the Company as set forth in the Registration Statement, any amendment thereto, the prospectus contained therein (the “Prospectus”) and supplements to the Prospectus (the “Prospectus Supplements”) filed pursuant to Rule 415 under the Act.

We have also acted as counsel to each of the subsidiaries of the Company listed on Schedule A (each a “New Registrant Guarantor” and collectively, the “New Registrant Guarantors”) and the subsidiaries of the Company listed on Schedule B (the “Existing Registrant Guarantors,” and collectively, with the New Registrant Guarantors, the “Registrant Guarantors”).

The Securities will be issued under an applicable Indenture to be entered into among the Company, the Registrant Guarantors and an Indenture Trustee. The Indentures together with the Registration Statement (including all exhibits thereto), the Prospectus, the Prospectus Supplements, the Debt Securities and the Guarantees are collectively referred to as the “Transaction Documents.”

In connection herewith, we have examined and relied without investigation, as to matters of fact, upon the Registration Statement and the exhibits thereto and such certificates, statements and results of inquiries of public officials and officers and representatives of the Company and the Registrant Guarantors and originals or copies, certified or otherwise identified to our satisfaction, of such other documents, corporate (or analogous) records, certificates and instruments as we have deemed necessary or appropriate to enable us to render the opinions expressed herein. We have assumed the genuineness of all signatures on all documents examined by us, the legal competence and capacity of natural persons, the authenticity of documents submitted to us as originals, and the conformity with authentic original documents of all documents submitted to us as copies or by facsimile or other means of electronic transmission, or which we obtained from the Commission’s Electronic Data Gathering, Analysis and Retrieval system (“Edgar”) or other sites maintained by a court or governmental authority or regulatory body and the authenticity of the originals of such latter documents. If any document we examined in printed, word processed or similar form has been filed with the Commission on Edgar or such court or governmental authority or regulatory body, we have assumed that the document so filed is identical to the document we examined except for formatting changes. When relevant facts were not independently established, we have relied without independent

Omega Healthcare Investors, Inc.

March 28, 2017

Page 2

investigation as to matters of fact upon statements of governmental officials and upon representations made in or pursuant to certificates and statements of appropriate representatives of the Company and the Registrant Guarantors.

We also have assumed that (i) at the time of execution, authentication, issuance and delivery of the Debt Securities and (ii) at the time of execution, issuance and delivery of the New Guarantees, the applicable Indenture will be the valid and legally binding obligation of the Indenture Trustee, enforceable against such Indenture Trustee in accordance with its terms.

We have assumed further that (i) at the time of execution, authentication, issuance and delivery of any of the Debt Securities, the applicable Indenture will be in full force and effect and will not have been terminated or rescinded by the Company or the Indenture Trustee and at the time of issuance and sale of any of the Debt Securities, the terms of such Debt Securities, and their issuance and sale, will have been established so as not to violate any applicable law or result in a default under or breach of any agreement or instrument binding upon the Company, and so as to comply with any requirement or restriction imposed by any court or governmental body having jurisdiction over the Company and (ii) at the time of execution, issuance and delivery of any New Guarantee offered by any New Registrant Guarantor, the New Guarantee will have been duly authorized, executed and delivered by such New Registrant Guarantor and will be in full force and effect and will not have been terminated or rescinded by such New Registrant Guarantor and at the time of issuance and sale of any New Guarantee by any New Registrant Guarantor, the terms of the New Guarantee, and its issuance and sale, will have been established so as not to violate any applicable law or result in a default under or breach of any agreement or instrument binding upon such New Registrant Guarantor, and so as to comply with any requirement or restriction imposed by any court or governmental body having jurisdiction over such New Registrant Guarantor.

Based upon the foregoing, in reliance thereon, and subject to the assumptions, comments, qualifications, limitations and exceptions stated herein and the effectiveness of the Registration Statement under the Act, we are of the opinion that:

In addition to the assumptions, comments, qualifications, limitations and exceptions set forth above, the opinions set forth herein are further limited by, subject to and based upon the following assumptions, comments, qualifications, limitations and exceptions:

(a) Our opinions set forth herein reflect only the application of applicable New York State law (excluding the securities, blue sky and criminal laws of such state, as to which we express no opinion), and to the

Omega Healthcare Investors, Inc.

March 28, 2017

Page 3

extent required by the foregoing opinions, the Delaware Limited Liability Company Act (6 Delaware Code Chapter 18), the Maryland General Corporation Law (Titles 1-3, Corporations and Associations, Maryland Code), and the Maryland Limited Liability Company Act (Title 4A, Corporations and Associations, Maryland Code) (the jurisdictions referred to in this sentence being sometimes collectively referred to herein as the “Opinion Jurisdictions” and the laws of the states of Delaware and Maryland, set forth in this section are referred to as the “Opinion Delaware and Maryland Laws”). The opinions set forth herein are made as of the date hereof and are subject to, and may be limited by, future changes in the factual matters set forth herein, and we undertake no duty to advise you of the same. The opinions expressed herein are based upon the law in effect (and published or otherwise generally available) on the date hereof, and we assume no obligation to revise or supplement these opinions should such law be changed by legislative action, judicial decision or otherwise. In rendering our opinion, we have not considered, and hereby disclaim any opinion as to, the application or impact of the laws of any jurisdiction other than the Opinion Jurisdictions and in the case of Delaware and Maryland, any laws of such States other than the Opinion Delaware and Maryland Laws (excluding any judicial or interpretive laws).

(b) Our opinions herein are subject to and may be limited by (i) applicable bankruptcy, insolvency, reorganization, receivership, moratorium and other similar laws affecting or relating to the rights and remedies of creditors generally including, without limitation, laws relating to fraudulent transfers or conveyances, preferences and equitable subordination; (ii) general principles of equity (regardless of whether considered in a proceeding in equity or at law); (iii) an implied covenant of good faith and fair dealing; (iv) requirements that a claim with respect to the Securities denominated other than in United States dollars (or a judgment denominated other than in United States dollars with respect to such a claim) be converted into United States dollars at a rate of exchange prevailing on a date determined pursuant to applicable law; and (v) governmental authority to limit, delay or prohibit the making of payments outside the United States or in foreign or composite currency.

(c) Our opinions are further subject to the effect of generally applicable rules of law arising from statutes, judicial and administrative decisions, and the rules and regulations of governmental authorities that: (i) limit or affect the enforcement of provisions of a contract that purport to require waiver of the obligations of good faith, fair dealing, diligence and reasonableness; (ii) limit the availability of a remedy under certain circumstances where another remedy has been elected; (iii) limit the enforceability of provisions releasing, exculpating or exempting a party from, or requiring indemnification of a party for, liability for its own action or inaction, to the extent the action or inaction involves negligence, recklessness, willful misconduct or unlawful conduct; (iv) may, where less than all of the contract may be unenforceable, limit the enforceability of the balance of the contract to circumstances in which the unenforceable portion is not an essential part of the agreed exchange; and (v) govern and afford judicial discretion regarding the determination of damages and entitlement to attorneys’ fees.

(d) We express no opinion as to the enforceability of any rights to indemnification or contribution provided for in any Transaction Document which are violative of public policy underlying any law, rule or regulation (including any federal or state securities law, rule or regulation) or the legality of such rights.

(e) We express no opinion as to the enforceability of (i) any provision in any Transaction Document purporting or attempting to (A) confer exclusive jurisdiction and/or venue upon certain courts or otherwise waive the defenses of forum non conveniens or improper venue, (B) confer subject matter jurisdiction on a court not having independent grounds therefor, (C) modify or waive the requirements for effective service of process for any action that may be brought, (D) waive the right of the Company, any Registrant Guarantor or any other person to a trial by jury, (E) provide that remedies are cumulative or that decisions by a party are conclusive, or (F) modify or waive the rights to notice, legal defenses, statutes of limitations or other benefits that cannot be waived under applicable law or (ii) any choice of law provision of any Transaction Document.

(f) We express no opinion as to the validity, binding effect or enforceability of any provision in the Indenture, any Debt Security or Guarantee that (i) purports to create joint and several liability for affiliated obligors except to the extent that each such affiliated obligor may be determined to have benefited from the

Omega Healthcare Investors, Inc.

March 28, 2017

Page 4

incurrence of the obligations by its affiliated obligors or whether such benefit may be measured other than by the extent to which the proceeds of the obligations incurred by its affiliated obligors are, directly or indirectly, made available to such affiliated obligor for its corporate, limited liability company or other analogous purposes or (ii) seeks to preserve the solvency of any Registrant Guarantor by purporting to limit the amount of the liability of, and/or to provide rights of contribution in favor of, such Registrant Guarantor.

(g) You have informed us that you intend to issue the Securities from time to time on a delayed or continuous basis, and this opinion is limited to the laws, including the rules and regulations, as in effect on the date hereof. We understand that prior to issuing any Securities you will afford us an opportunity to review the operative documents pursuant to which such Securities are to be issued (including the applicable Prospectus Supplement) and will file such supplement or amendment to this opinion letter (if any) as we may reasonably consider necessary or appropriate by reason of the terms of such Securities.

We do not render any opinions except as set forth above. We hereby consent to the filing of this opinion as an exhibit to the Registration Statement and to the use of our name under the caption “Legal Matters” in the Prospectus. In giving such consent, we do not thereby concede that we are within the category of persons whose consent is required under Section 7 of the Act or the Rules and Regulations of the Commission thereunder.

Very truly yours,

/s/ Bryan Cave LLP

Omega Healthcare Investors, Inc.

Schedule A

Page 1

Schedule A

Omega Healthcare Investors, Inc.

Schedule B

Page 1

Schedule B

Omega Healthcare Investors, Inc.

Schedule B

Page 2

Omega Healthcare Investors, Inc.

Schedule B

Page 3

Omega Healthcare Investors, Inc.

Schedule B

Page 4

Omega Healthcare Investors, Inc.

Schedule B

Page 5

Omega Healthcare Investors, Inc.

Schedule B

Page 6

Omega Healthcare Investors, Inc.

Schedule B

Page 7

Omega Healthcare Investors, Inc.

Schedule B

Page 8

Omega Healthcare Investors, Inc.

Schedule B

Page 9

Omega Healthcare Investors, Inc.

Schedule B

Page 10

Omega Healthcare Investors, Inc.

Schedule B

Page 11

Omega Healthcare Investors, Inc.

Schedule B

Page 12